Invention Grant
- Patent Title: Heterocyclic amide derivatives as P2X7 receptor antagonists
- Patent Title (中): 杂环酰胺衍生物作为P2X7受体拮抗剂
-
Application No.: US14373338Application Date: 2013-01-18
-
Publication No.: US09409917B2Publication Date: 2016-08-09
- Inventor: Kurt Hilpert , Francis Hubler , Thierry Kimmerlin , Dorte Renneberg , Simon Stamm
- Applicant: Kurt Hilpert , Francis Hubler , Thierry Kimmerlin , Dorte Renneberg , Simon Stamm
- Applicant Address: CH Allschwil
- Assignee: ACTELION PHARMACEUTICALS LTD.
- Current Assignee: ACTELION PHARMACEUTICALS LTD.
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/IB2012/050282 20120120
- International Application: PCT/IB2013/050479 WO 20130118
- International Announcement: WO2013/108227 WO 20130725
- Main IPC: C07D491/048
- IPC: C07D491/048
Abstract:
The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, X and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.
Public/Granted literature
- US20150025075A1 HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS Public/Granted day:2015-01-22
Information query
